Liz Galle - Jan 18, 2022 Form 4 Insider Report for CVRx, Inc. (CVRX)

Role
VP of Global Clinical Research
Signature
/s/ Amy C. Seidel, Attorney-in-Fact
Stock symbol
CVRX
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 05:14 PM
Previous filing
Jun 29, 2021
Next filing
Aug 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVRX Stock Option (right to buy) Award $0 +25.9K $0.00 25.9K Jan 18, 2022 Common Stock 25.9K $9.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter.